《亚洲股市》韩股及日经续升1%及1.5% 惟马股逆市续软
美国批准将已康复新冠病人血浆用於治疗其他新冠患者,另据报美国政府正考虑加速审批阿斯利康与牛津大学研发现正处於试验阶段新冠疫苗,冀望11月初大选前在美国使用,市场憧憬新冠肺炎疗法有进展。欧美主要股市全面报升,其中美股连升第三天,30只道指成份股普遍造好,工业、石油、金融及消费股普遍升逾1%-2%,Like续涨近2%屡创纪录高、波音及陶氏更急涨5.8%-6.4%,但联合健康逆跌1.7%,道指高收续涨378点或近1.4%重越28,300;受惠疫苗有进展的达美航空、联合航空、美国航空及嘉年华邮轮急涨9.3%-10.5%,挪威邮轮也涨7.6%;苹果五连涨突破500美元大关屡破顶,但升幅由最多3.5%,收窄至仅升1.2%收503.43美元,屡破顶的Tesla再创纪录高後倒跌1.7%,英特尔及思科也逆软,连续三天破顶的纳指由曾升1.3%至11,462,收窄至仅升0.6%,标普续升1%高收3,431第二天破顶。此外,欧洲主要股市全面追弹1.6%-2.4%,意法德最强。
美股期货全面续升0.2%-0.4%,道指期货续升113点或0.4%,报28,352。亚太区股市早段普遍向好。美元兑日圆於亚洲偏稳105.95,日经继昨天反覆续弹0.3%後,今早发力急升341点或1.5%报23,326。台湾加权指数连弹第三天,报12,754,升0.8%。
南韩8月消费信心续升至半年高,韩股继昨天续弹1%後,今早再升1%报2,354。新西兰连升第三天,报11,957,续升0.3%。澳洲200续弹0.6%报6,165。星股续弹0.6%报2,553。
事隔三周港汇再度触及强方兑换保证,金管局今早於纽约交易时段再入市买美元,沽出6.43亿港元。港股继昨天受惠重磅股友邦(01299.HK)续升4.7%及腾讯(00700.HK)高收续升5.8%推动急涨437点或1.7%高收25,551後,今早在汇控(00005.HK)高开1%支撑高开35点或0.1%报25,586,最高见25,621遇压,现造25,586,续升34点。
沪指及深成继昨天续升0.1%及1.4%後,今早均高开0.2%,分别报3,392及13,692,前者升幅扩至0.5%报3,402,後者报13,708,续升0.3%。 不过,马股续跌0.2%报1,565。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.